S. Lawrence Librach, MD

Articles by S. Lawrence Librach, MD

Palliative Care and Oncology: Integration Leads to Better Care

ByKristopher Dennis, MD, FRCPC,S. Lawrence Librach, MD,Edward Chow, MBBS, MSc, PhD, FRCPC

November 30th 2011

Patients with advanced progressive cancer require care plans that address their physical, emotional, and psychosocial needs, as well as their goals of care.

Latest Updated Articles

Palliative Care and Oncology: Integration Leads to Better Care
November 30th 2011

Trending on CancerNetwork

How Effective and Safe is EUS-Guided Alpha DaRT in Pancreatic Cancer?

Cevostamab May Fill Gap in Multiple Myeloma Armamentarium

131 Primary Results From ASCENT-03: A Randomized Phase 3 Study of Sacituzumab Govitecan (SG) vs Chemotherapy (Chemo) in Patients (pts) With Previously Untreated Advanced Triple-Negative Breast Cancer (TNBC) Who Are Unable to Receive PD-(L)1 Inhibitors (PD-[L]1i)

S. Lawrence Librach, MD

Articles by S. Lawrence Librach, MD

Palliative Care and Oncology: Integration Leads to Better Care

Latest Updated Articles

Trending on CancerNetwork

How Effective and Safe is EUS-Guided Alpha DaRT in Pancreatic Cancer?

Cevostamab May Fill Gap in Multiple Myeloma Armamentarium

131 Primary Results From ASCENT-03: A Randomized Phase 3 Study of Sacituzumab Govitecan (SG) vs Chemotherapy (Chemo) in Patients (pts) With Previously Untreated Advanced Triple-Negative Breast Cancer (TNBC) Who Are Unable to Receive PD-(L)1 Inhibitors (PD-[L]1i)

ASCO Updates 340B Policy Statement to Expand Access, Improve Transparency

FDA Accepts Protocol Amendment to Phase 3 NANORAY-312 Trial in HNSCC